Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 37

Results For "RAS"

1972 News Found

Axten Hospitals raises Rs 2.5 crore from PedalStart to scale surgical care network
Hospitals | April 20, 2026

Axten Hospitals raises Rs 2.5 crore from PedalStart to scale surgical care network

The investment will support the company’s plans to expand its network of specialised surgical hospitals across India.


FDA pushes forward on gene-editing therapies with new safety roadmap
Biotech | April 20, 2026

FDA pushes forward on gene-editing therapies with new safety roadmap

Genome editing holds extraordinary promise for treating previously incurable genetic diseases


NHA convenes Chintan Shivir to accelerate Ayushman Bharat schemes
Policy | April 18, 2026

NHA convenes Chintan Shivir to accelerate Ayushman Bharat schemes

Focus on preventive, tech-driven healthcare and digital ecosystem reforms under AB PM-JAY and ABDM


Beyond beds and buildings: The quiet capital shift reshaping healthcare
Opinion | April 17, 2026

Beyond beds and buildings: The quiet capital shift reshaping healthcare

The investment case for health technology in India is frequently overstated in one direction and understated in another


Piramal Pharma, Ajinomoto Bio-Pharma collaborate to accelerate ADC development
Biopharma | April 17, 2026

Piramal Pharma, Ajinomoto Bio-Pharma collaborate to accelerate ADC development

Collaboration integrates AJICAP™ technology with global manufacturing capabilities to streamline antibody-drug conjugate pipelines


DKSH and Sanofi join forces to expand access to cardio & diabetes treatments in Southeast Asia
Supply Chain | April 17, 2026

DKSH and Sanofi join forces to expand access to cardio & diabetes treatments in Southeast Asia

The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease


Inter-ministerial study to track zoonotic spillover risks in India
Public Health | April 17, 2026

Inter-ministerial study to track zoonotic spillover risks in India

One Health-based surveillance model to focus on bird sanctuaries and high-risk human populations


Morepen Laboratories secures fourth consecutive USFDA ‘NIL 483’ inspection
Drug Approval | April 17, 2026

Morepen Laboratories secures fourth consecutive USFDA ‘NIL 483’ inspection

Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions


ACC Asia 2026 to spotlight next-gen cardiovascular care across Asia-Pacific
Healthcare | April 17, 2026

ACC Asia 2026 to spotlight next-gen cardiovascular care across Asia-Pacific

American College of Cardiology and Korean Society of Cardiology convene global experts to address rising cardiometabolic burden